TABLE 4.
Comparison of VITEK 2 MICs with reference MICs for the 72 levofloxacin-nonsusceptible isolates
Drug | No. of VITEK 2 MICs that differed from reference MICsa
|
% EAb | ||||||
---|---|---|---|---|---|---|---|---|
−3 | −2 | −1 | Same | +1 | +2 | +3 | ||
Gatifloxacin | 1 | 0 | 23 | 43 | 5 | 0 | 0 | 98.6 |
Moxifloxacin | 1 | 0 | 11 | 41 | 18 | 1 | 0 | 97.2 |
Dilutions indicate the number of VITEK 2 MIC dilutions as compared to reference MICs.
EA, essential agreement (percent VITEK 2 MICs within one dilution of reference MICs).